ArticleHealth science reports2025
Atherogenic Index of Plasma (AIP) as a Long-Term Prognostic Factor Following CABG: Unveiling Insights From a Large-Scale Tertiary Center Registry Analysis.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic value of the atherogenic index of plasma in patients with multivessel coronary disease undergoing CABG: a retrospective cohort study.Lipids in health and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The role of the atherogenic index of plasma (AIP) in predicting major adverse cerebro-cardiovascular events (MACCE) after coronary artery bypass grafting (CABG) surgery has not been fully explored. The present study aims to investigate the prognostic value of AIP in predicting MACCE and its individual components following CABG. Methods: This is a large-scale retrospective study conducted on patients who underwent isolated CABG. The primary outcomes were all-cause mortality and MACCE, which included acute coronary syndrome (ACS), Cerebrovascular accident (CVA)/transient ischemia attack (TIA), revascularization, and all-cause mortality. Proportional Hazard (PH) Cox regression, considering stabilized Inverse probability weightings (IPW), was conducted after verifying the PH assumption. Results: Totally, 23,432 patients analyzed with median 111.4-month follow-up duration. After weighting all variables, a higher AIP was associated with a significantly increased risk of MACCE (HR = 1.05; 95% CI: 1.01-1.09; Conclusion: AIP predicts MACCE, revascularization, and ACS after CABG, serving as a readily accessible prognostic factor.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.